Skip to content

Intracellular Nitric Oxide as a Biomarker for Increased Susceptibility for Systemic Inflammation

A biomarker assay for measuring systemic inflammatory responses which utilizes the expression of inducible nitric oxide in blood

Published: 3rd February 2022
Intracellular Nitric Oxide as a Biomarker for Increased Susceptibility for Systemic Inflammation
Source: Ladanifer, https://stock.adobe.com/uk/389339206, stock.adobe.com
Patents
  • A provisional patent has been filed: 16/969,093
IP Status
  • Provisional patent
  • Patent application submitted
Seeking
  • Development partner